Accelerating Nigeria’s tuberculosis response on stronger private partnerships

attacks the lungs, leaving affected patients with mainly severe coughs is preventable and curable.

For some health sector stakeholders, it is increasingly unsettling to watch how poor response to early detection fuels and sustains the rise in cases of tuberculosis, a “residual pandemic” that kills an estimated 440,000 people each year in Africa’s most populated country, Nigeria. The infe

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```